Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Kimberly-Clark to buy maker of Tylenol

Digest more
 · 1d · on MSN
Kimberly-Clark to Buy Tylenol Maker Kenvue. Why the Stock Market Hates the Deal.
The firm noted that Kimberly-Clark is paying a “significant equity premium” to acquire Kenvue. The deal values Kenvue at $19.25 a share. Even with Monday’s gains, the stock was trading at under $17.

Continue reading

 · 1d · on MSN
Why Kimberly-Clark Stock Just Dropped
 · 1d
Kimberly-Clark to buy maker of Tylenol in $48.7 billion cash-and-stock deal
1d

With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...
6d

Are Kimberly-Clark Shares Trading Below Their True Value After Investment in Sustainable Packaging?

If you find yourself weighing whether to hold, buy, or simply keep an eye on Kimberly-Clark, you are not alone. Investors ...
6d

Kimberly-Clark: Lowest P/E Since 2013, Everyone Should Consider This Defensive Gem

Discover why Kimberly-Clark Corporation could be a smart buy now with its improved valuation and highest dividend yield in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms